Human cord blood applications in cell therapy: looking back and look ahead

Bibliography

• Gluckman E, Broxmeyer HA, Auerbach AD, Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32
   PubMed Web of Science ®Google Scholar
• Ortiz-Gonzalez XR, Keene CD, Verfaillie CM, Low WC. Neural induction of adult bone marrow and umbilical cord stem cells. Curr Neurovasc Res 2004;1:207-13
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
   PubMed Web of Science ®Google Scholar
• Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol 2000;61:834-40
   PubMed Web of Science ®Google Scholar
• Barker JN, Davies SM, DeFor T, Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-61
   PubMed Web of Science ®Google Scholar
• Vilmer E, Sterkers G, Rahimy C, HLA-mismatched cord-blood transplantation in a patient with advanced leukemia. Transplantation 1992;53:1155-7
   PubMed Web of Science ®Google Scholar
• Gluckman E, Ruggeri A, Rocha V, Family-directed umbilical cord blood banking. Haematologica 2011;96:1700-7
   PubMed Web of Science ®Google Scholar
• Ballen KK. New trends in umbilical cord blood transplantation. Blood 2005;105:3786-92
   PubMed Web of Science ®Google Scholar
• Petropoulou AD, Rocha V. Risk factors and options to improve engraftment in unrelated cord blood transplantation. Stem Cells Int 2011;2011:610514
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Eapen M, Rubinstein P Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004;351:2265-75
   PubMed Web of Science ®Google Scholar
• Cohen Y, Nagler A. Umbilical cord blood transplantation–how, when and for whom? Blood Rev 2004;18:167-79
   PubMed Web of Science ®Google Scholar
• Avery S, Barker JN. Cord blood transplants: one, two or more units? Curr Opin Hematol 2010;17:531-7
   PubMed Web of Science ®Google Scholar
• Reinisch A, Bartmann C, Rohde E, Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2007;2:371-82
   PubMed Web of Science ®Google Scholar
• Frassoni F, Gualandi F, Podesta M, Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 2008;9:831-9
   PubMed Web of Science ®Google Scholar
• Liu H, Rich ES, Godley L, Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011;118:6438-45
   PubMed Web of Science ®Google Scholar
• Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007;2:301-9
   PubMedGoogle Scholar
• Yoshida S, Ishikawa F, Kawano N, Human cord blood–derived cells generate insulin-producing cells in vivo. Stem Cells 2005;23:1409-16
   PubMed Web of Science ®Google Scholar
• Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004;325:665-9
   PubMed Web of Science ®Google Scholar
• Haller MJ, Viener HL, Wasserfall C, Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008;36:710-15
   PubMed Web of Science ®Google Scholar
• Haller MJ, Wasserfall CH, McGrail KM, Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009;32:2041-6
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lin B, Darflinger R, Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS One 2009;4:e4226
   PubMed Web of Science ®Google Scholar
• Greco N, Laughlin MJ. Umbilical cord blood stem cells for myocardial repair and regeneration. Methods Mol Biol 2010;660:29-52
   PubMedGoogle Scholar
• Boltze J, Schmidt UR, Reich DM, Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant 2011 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22182968
   Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Zigova T Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003;12:255-70
   PubMedGoogle Scholar
• Kaner T, Karadag T, Cirak B, The effects of human umbilical cord blood transplantation in rats with experimentally induced spinal cord injury. J Neurosurg Spine 2010;13:543-51
   PubMed Web of Science ®Google Scholar
• Haase A, Olmer R, Schwanke K, Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009;5:434-41
   PubMed Web of Science ®Google Scholar
• Hu K, Yu J, Suknuntha K, Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011;117:e109-19
   PubMed Web of Science ®Google Scholar
• Ye Z, Liu CF, Jang YY. Hematopoietic cells as sources for patient-specific iPSCs and disease modeling. Cell Cycle 2011;10:2840-4
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Lee MR, Hangoc G, Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011;117:4773-7
   PubMed Web of Science ®Google Scholar
• Giorgetti A, Montserrat N, Aasen T, Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009;5:353-7
   PubMed Web of Science ®Google Scholar
• Narsinh KH, Wu JC. Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead. Mol Ther 2010;18:1061-3
   PubMed Web of Science ®Google Scholar
• Kazuki Y, Hiratsuka M, Takiguchi M, Complete genetic correction of ips cells from duchenne muscular dystrophy. Mol Ther 2009;18:386-93
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhan H, Mali P, Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114:5473-80
   PubMed Web of Science ®Google Scholar
• Ban H, Nishishita N, Fusaki N, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 2011;108:14234-9
   PubMed Web of Science ®Google Scholar
• Meng X, Neises A, Su RJ, Efficient reprogramming of human cord blood CD34(+) cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther 2012;20:408-16
   PubMed Web of Science ®Google Scholar
• Rodriguez-Piza I, Richaud-Patin Y, Vassena R, Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 2009;28:36-44
   Web of Science ®Google Scholar
• Vallier L, Alexander M, Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005;118:4495-509
   PubMed Web of Science ®Google Scholar
• Ludwig TE, Levenstein ME, Jones JM, Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006;24:185-7
   PubMed Web of Science ®Google Scholar
• Zhou H, Ding S. Evolution of induced pluripotent stem cell technology. Curr Opin Hematol 2010;17:276-80
   PubMed Web of Science ®Google Scholar
• Sun N, Panetta NJ, Gupta DM, Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009;106:15720-5
   PubMed Web of Science ®Google Scholar
• Crook JM, Peura TT, Kravets L, The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007;1:490-4
   PubMed Web of Science ®Google Scholar
• Bock C, Kiskinis E, Verstappen G, Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011;144:439-52
   PubMed Web of Science ®Google Scholar
• Querol S, Mufti GJ, Marsh SG, Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? Haematologica 2009;94:536-41
   PubMed Web of Science ®Google Scholar
• Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol 2008;26:739-40
   PubMed Web of Science ®Google Scholar
• Pedron B, Duval M, Elbou OM, Common genomic HLA haplotypes contributing to successful donor search in unrelated hematopoietic transplantation. Bone Marrow Transplant 2003;31:423-7
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Will iPS cells enhance therapeutic applicability of cord blood cells and banking? Cell Stem Cell 2010;6:21-4
   PubMed Web of Science ®Google Scholar
• Chin MH, Mason MJ, Xie W, Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-23
   PubMed Web of Science ®Google Scholar
• Doi A, Park IH, Wen B, Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-3
   PubMed Web of Science ®Google Scholar
• Hu BY, Weick JP, Yu J, Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010;107:4335-40
   PubMed Web of Science ®Google Scholar